Congratulations, 23andMe. You're a public stock now!
News & Analysis: VG Acquisition Corp.
Here's why long-term investors might want to take a look at this genetics company before it's officially public.
This consumer-facing company could have massive potential.
Two of these have identified their targets, and the other has some interesting possibilities.
23andMe and Butterfly Networks are two private biotech companies hitting the public markets soon.
Let's look at why a consumer genomics leader has finally decided to go public.